Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
Condition(s):Non-small Cell Lung Cancer MetastaticLast Updated:August 3, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer MetastaticLast Updated:August 3, 2023Recruiting
Condition(s):Lung Neoplasms; Lung Cancer; Neoplasm of Lung; Non Small Cell Lung CancerLast Updated:February 18, 2021Completed
Condition(s):Gastric Cancer; Circulating Tumor DNA (ctDNA)Last Updated:February 6, 2023Recruiting
Condition(s):Prostate Cancer; Renal Cell Cancer; Bladder Cancer; Ureter CancerLast Updated:December 13, 2019Recruiting
Condition(s):Uveal MelanomaLast Updated:January 31, 2024Completed
Condition(s):Advanced Colorectal Cancer; Circulating Tumor DNALast Updated:August 10, 2022Recruiting
Condition(s):Head and Neck Neoplasm; Carcinoma, Squamous CellLast Updated:November 28, 2023Recruiting
Condition(s):Adenocarcinoma EsophagusLast Updated:March 15, 2024Recruiting
Condition(s):Colorectal Cancer; Pancreatic Adenocarcinoma; Gastric Cancer; Hepatocellular Carcinoma; Non-small Cell Lung Cancer; Bladder Cancer; Melanoma; Ovarian Cancer; Adrenocortical Cancer; Breast Cancer; Other CancerLast Updated:November 20, 2018Unknown status
Condition(s):Stage III Colorectal Cancer; Circulating Tumor DNALast Updated:December 17, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.